Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates

Company Performance - Schrodinger, Inc. reported a quarterly loss of $0.52 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.40, representing an earnings surprise of -30% [1] - The company's revenues for the quarter ended September 2024 were $35.29 million, missing the Zacks Consensus Estimate by 13.85%, and down from $42.57 million a year ago [2] - Over the last four quarters, Schrodinger has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Stock Movement and Outlook - Schrodinger shares have declined approximately 45.4% since the beginning of the year, contrasting with the S&P 500's gain of 25.8% [3] - The company's earnings outlook is mixed, with the current consensus EPS estimate for the coming quarter at -$0.26 on revenues of $88.58 million, and -$2.19 on revenues of $211.65 million for the current fiscal year [7] Industry Context - Schrodinger operates within the Zacks Medical Info Systems industry, which is currently ranked in the top 19% of over 250 Zacks industries, indicating a favorable industry outlook [8] - The performance of Schrodinger's stock may be influenced by the overall outlook for the industry, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]